Alistipes Bacteremia in Older Patients with Digestive and Cancer Comorbidities, Japan, 2016–2023

IF 6.6 2区 医学 Q1 IMMUNOLOGY Emerging Infectious Diseases Pub Date : 2025-03-07 DOI:10.3201/eid3104.241284
Naoki Watanabe, Tomohisa Watari, Naoto Hosokawa, Yoshihito Otsuka
{"title":"Alistipes Bacteremia in Older Patients with Digestive and Cancer Comorbidities, Japan, 2016–2023","authors":"Naoki Watanabe, Tomohisa Watari, Naoto Hosokawa, Yoshihito Otsuka","doi":"10.3201/eid3104.241284","DOIUrl":null,"url":null,"abstract":"<p>The clinical characteristics of <em>Alistipes</em> bacteremia remain insufficiently understood. We retrospectively analyzed 13 cases of <em>Alistipes</em> bacteremia at a tertiary care center in Japan. Ten patients were <span>&gt;</span>65 years of age; 7 were female and 3 male. Of 9 patients with comorbidities, 7 had solid tumors or hematological malignancies and 11 had gastrointestinal symptoms. Isolates identified were <em>Alistipes finegoldii</em> in 4 cases, <em>A. onderdonkii</em> in 4, <em>A. putredinis</em> in 3, <em>A. indistinctus</em> in 2, and <em>A. ihumii</em> in 1. Ten strains exhibited low MICs against β-lactam/β-lactamase inhibitors and metronidazole. We observed high MICs against penicillin, ceftriaxone, and minocycline. Several strains harbored antimicrobial resistance genes, including <em>adeF</em>, <em>tet(Q)</em>, <em>cfxA3</em>, <em>cfxA4</em>, and <em>ermG</em>. Twelve patients received β-lactam/β-lactamase inhibitors; 2 patients with solid tumors experienced septic shock and died. <em>Alistipes</em> bacteria can translocate from the gastrointestinal tract into the bloodstream, particularly in cases of inflammation, obstruction, or perforation, leading to severe infections.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":"17 1","pages":""},"PeriodicalIF":6.6000,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3201/eid3104.241284","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The clinical characteristics of Alistipes bacteremia remain insufficiently understood. We retrospectively analyzed 13 cases of Alistipes bacteremia at a tertiary care center in Japan. Ten patients were >65 years of age; 7 were female and 3 male. Of 9 patients with comorbidities, 7 had solid tumors or hematological malignancies and 11 had gastrointestinal symptoms. Isolates identified were Alistipes finegoldii in 4 cases, A. onderdonkii in 4, A. putredinis in 3, A. indistinctus in 2, and A. ihumii in 1. Ten strains exhibited low MICs against β-lactam/β-lactamase inhibitors and metronidazole. We observed high MICs against penicillin, ceftriaxone, and minocycline. Several strains harbored antimicrobial resistance genes, including adeF, tet(Q), cfxA3, cfxA4, and ermG. Twelve patients received β-lactam/β-lactamase inhibitors; 2 patients with solid tumors experienced septic shock and died. Alistipes bacteria can translocate from the gastrointestinal tract into the bloodstream, particularly in cases of inflammation, obstruction, or perforation, leading to severe infections.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Alistipes菌血症在老年消化和癌症合并症患者中的应用,日本,2016-2023
阿利斯提普菌血症的临床特征仍不充分了解。我们回顾性分析了日本一家三级保健中心的13例阿利斯提普菌血症。10例患者年龄65岁;其中女性7人,男性3人。9例合并症患者中,7例有实体瘤或血液系统恶性肿瘤,11例有胃肠道症状。分离到细谷阿利斯特4例,翁氏阿利斯特4例,腐臭阿利斯特3例,无区别阿利斯特2例,腐殖阿利斯特1例。10株菌株对β-内酰胺/β-内酰胺酶抑制剂和甲硝唑表现出低mic。我们观察到青霉素、头孢曲松和米诺环素的mic值较高。一些菌株携带抗菌耐药基因,包括adeF、tet(Q)、cfxA3、cfxA4和ermG。12例患者接受β-内酰胺/β-内酰胺酶抑制剂治疗;2例实体瘤患者感染性休克死亡。Alistipes细菌可以从胃肠道转移到血液中,特别是在炎症、阻塞或穿孔的情况下,导致严重的感染。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Emerging Infectious Diseases
Emerging Infectious Diseases 医学-传染病学
CiteScore
17.30
自引率
1.70%
发文量
505
审稿时长
1 months
期刊介绍: Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.
期刊最新文献
Rickettsia lanei Rickettsiosis, Oregon, USA, 2025. Detecting Influenza A(H5N1) Viruses through Severe Acute Respiratory Infection Surveillance, Cambodia. Multiplex PCR to Differentiate Monkeypox Virus Clades. Vesicular Disease Caused by Seneca Valley Virus in Pigs, England, 2022. Genomic Analysis of Doxycycline Resistance-Associated 16S rRNA Mutations in Treponema pallidum Subspecies pallidum.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1